Oral and intravenous disposition of cyclosporine in psoriatic patients

Ther Drug Monit. 1995 Jun;17(3):302-4.

Abstract

After informed consent was obtained and with the approval of the Local Ethical Committee, cyclosporine A (CsA) kinetics was studied in 63 psoriatic patients by giving them 2.5 mg/kg CsA orally. In order to calculate oral bioavailability, F, 22 patients were given the same dose i.v. Values of the calculated kinetic parameters were oral F = 22-63%; half-life, t1/2 beta, = 11.05-13.70 h; volume of distribution, Vd, = 4.00-5.02/L/kg; total body clearance, Cl, = 4.25-4.14 ml/min/kg. The area under the blood concentration time curve was more closely related to the dose (r = 0.66) than were trough levels (r = 0.52). No significant relationship was observed between the kinetic parameters studied and the age of the patient.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Adult
  • Aged
  • Aged, 80 and over
  • Cyclosporine / administration & dosage
  • Cyclosporine / pharmacokinetics*
  • Female
  • Humans
  • Injections, Intravenous
  • Male
  • Middle Aged
  • Psoriasis / drug therapy*
  • Psoriasis / metabolism

Substances

  • Cyclosporine